Hyundai Tonguezone Plaster (Felbinac)
Felbinac 35mg
Patch · OTC medication
Hyundai Pharmaceutical Co., Ltd.
MFDS item code 200403200 · Notified 2004.10.08
Relief of pain and inflammation from degenerative arthritis (osteoarthritis), shoulder periarthritis, etc.
This medication is used for degenerative arthritis, shoulder periarthritis, tendinitis and paratendinitis, lateral epicondylitis (tennis elbow), muscle pain, and post-traumatic swelling and pain.
After removing the release liner from the patch, apply 1 patch to the affected area twice a day.
This medication should not be used by individuals who are allergic or hypersensitive to the ingredients of this medication or to Felbinac preparations. Patients who have experienced asthma attacks due to aspirin or other non-steroidal anti-inflammatory drugs, or who have a history of asthma, should avoid using this medication as it may exacerbate asthma symptoms. Additionally, individuals who have experienced urticaria or acute rhinitis due to aspirin or non-steroidal anti-inflammatory drugs should exercise caution as symptoms may reappear. In patients with bronchial asthma, this medication can trigger asthma attacks, so it should be used with caution. While using this medication, skin irritation, redness, rashes, eczema, contact dermatitis, irritation, or blisters may occur, and use should be discontinued if symptoms worsen. Rarely, hypersensitivity reactions such as urticaria or extensive rashes and bronchospasm may occur, requiring caution. Occasionally, gastrointestinal disturbances may occur, and if these symptoms appear, consultation with a healthcare professional is advised. This medication is symptomatic therapy that alleviates inflammation or pain and is not a treatment for the underlying cause, so its therapeutic effect may be limited. When using this medication on areas of inflammation accompanied by skin infections, it should be used alongside antibiotics or antifungals to prevent the infection from worsening, and the condition should be closely monitored. For chronic conditions such as degenerative arthritis, it is essential to consider other treatment options alongside drug therapy and to carefully observe for potential side effects. In late pregnancy, this medication may cause dystocia or delay in labor, so it should not be used by pregnant or potentially pregnant women or nursing mothers. The safety in children has not been sufficiently verified, so caution is necessary when using it in pediatric patients. Do not apply this medication on damaged skin or mucous membranes, or on areas with eczema or rashes, and take care to avoid contact with eyes or mucous membranes. When used on damaged skin, temporary irritation or numbness may occur; hence, it requires caution during application. Additionally, this medication should not be used in a sealed bandage method.
Urticaria, extensive rash accompanied by bronchospasm (hypersensitivity), asthma attacks
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that does not allow light to enter. Furthermore, it is crucial to maintain a storage temperature at room temperature, between 1 to 30 degrees Celsius, to preserve its efficacy over time.
This medication is a transdermal patch with a colorless and transparent adhesive substance coated on a backing layer, covered with a release liner on a solid surface.
10 pieces per box
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Felbinac 35mg
Patch · OTC medication
Hyundai Pharmaceutical Co., Ltd.
Felbinac 58.5mg
OTC medication
DaeHwa Pharmaceutical Co., Ltd.
Felbinac 35mg
Patch · OTC medication
Shin Shin Pharmaceutical Co., Ltd.
Felbinac 48mg
OTC medication
TDS Pharm Co., Ltd.
Felbinac 35mg
Patch · OTC medication
JW Pharmaceutical Co., Ltd.
Felbinac 35mg
Patch · OTC medication
Boryung Pharmaceutical Co., Ltd.
Felbinac 35mg
Patch · OTC medication
Yuhan Corporation
Felbinac 49mg
Patch · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.